Furthermore, by the time of diagnosis with T2D, beta-cell function and insulin secretion were significantly impaired, with residual beta-cell function as a major predictor of glycemic control in pediatric patients with recently diagnosed T2D (6, 7). This evidence concerns the gene INS and type 2 diabetes mellitus.